FY2024 Earnings Estimate for Humana Issued By Zacks Research

Humana Inc. (NYSE:HUM) – Research analysts at Zacks Research boosted their FY2024 earnings per share estimates for shares of Humana in a research note issued on Wednesday, November 13th. Zacks Research analyst D. Chatterjee now forecasts that the insurance provider will post earnings of $16.04 per share for the year, up from their previous estimate of $16.01. The consensus estimate for Humana’s current full-year earnings is $15.83 per share. Zacks Research also issued estimates for Humana’s Q1 2025 earnings at $6.37 EPS and Q2 2025 earnings at $6.25 EPS.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%.

A number of other equities analysts have also issued reports on HUM. Stephens reaffirmed an “equal weight” rating and issued a $250.00 target price on shares of Humana in a research report on Wednesday, October 9th. Oppenheimer cut their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. KeyCorp assumed coverage on Humana in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. UBS Group cut their target price on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, October 4th. Finally, Wells Fargo & Company cut their target price on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Stock Performance

Humana stock opened at $282.97 on Friday. The stock’s 50 day moving average price is $284.64 and its 200 day moving average price is $332.14. Humana has a one year low of $213.31 and a one year high of $527.18. The firm has a market capitalization of $34.07 billion, a PE ratio of 25.06, a price-to-earnings-growth ratio of 2.29 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Institutional Investors Weigh In On Humana

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Paloma Partners Management Co raised its stake in shares of Humana by 33.7% during the third quarter. Paloma Partners Management Co now owns 853 shares of the insurance provider’s stock valued at $270,000 after purchasing an additional 215 shares in the last quarter. Maverick Capital Ltd. grew its holdings in Humana by 3.3% during the third quarter. Maverick Capital Ltd. now owns 197,892 shares of the insurance provider’s stock worth $62,680,000 after acquiring an additional 6,322 shares during the period. PDT Partners LLC grew its holdings in Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after acquiring an additional 2,660 shares during the period. Public Sector Pension Investment Board grew its holdings in Humana by 13.0% during the third quarter. Public Sector Pension Investment Board now owns 5,222 shares of the insurance provider’s stock worth $1,654,000 after acquiring an additional 600 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Humana by 1.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 856,954 shares of the insurance provider’s stock worth $271,432,000 after acquiring an additional 9,100 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.